
Diabetes Technology & Therapeutics is
the only peer-reviewed journal providing healthcare professionals with
information on new devices, drugs, drug delivery systems, and software
for managing patients with diabetes. This leading international journal
delivers practical information and comprehensive coverage of
cutting-edge technologies and therapeutics in the field, and highlights
new pharmacological and device developments to optimize patient care.
Diabetes Technology & Therapeutics is under the editorial leadership of Editor-in-Chief Satish K. Garg, MD, University of Colorado Denver, Barbara Davis Center for Childhood Diabetes; Senior Editors Jay S. Skyler, MD, MACP, University of Miami Miller School of Medicine, and Irl B. Hirsch, MD, University of Washington Medical Center–Roosevelt; and other leading investigators.